GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Operating Margin %

Innovative Pharmaceutical Biotech (HKSE:00399) Operating Margin % : -251.99% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Innovative Pharmaceutical Biotech's Operating Income for the six months ended in Mar. 2024 was HK$-7.22 Mil. Innovative Pharmaceutical Biotech's Revenue for the six months ended in Mar. 2024 was HK$2.87 Mil. Therefore, Innovative Pharmaceutical Biotech's Operating Margin % for the quarter that ended in Mar. 2024 was -251.99%.

Warning Sign:

Innovative Pharmaceutical Biotech Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -7.6%.

The historical rank and industry rank for Innovative Pharmaceutical Biotech's Operating Margin % or its related term are showing as below:

HKSE:00399' s Operating Margin % Range Over the Past 10 Years
Min: -256.38   Med: -181   Max: -95
Current: -242.7


HKSE:00399's Operating Margin % is ranked worse than
98.64% of 1104 companies
in the Retail - Cyclical industry
Industry Median: 3.6 vs HKSE:00399: -242.70

Innovative Pharmaceutical Biotech's 5-Year Average Operating Margin % Growth Rate was -7.60% per year.

Innovative Pharmaceutical Biotech's Operating Income for the six months ended in Mar. 2024 was HK$-7.22 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was HK$-14.31 Mil.

Warning Sign:

Innovative Pharmaceutical Biotech Ltd has never been profitable in the past 3 years. It lost money every year.


Innovative Pharmaceutical Biotech Operating Margin % Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Operating Margin % Chart

Innovative Pharmaceutical Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -221.94 -140.79 -218.52 -256.38 -203.76

Innovative Pharmaceutical Biotech Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -186.27 -330.07 -166.68 -251.99 -233.91

Competitive Comparison of Innovative Pharmaceutical Biotech's Operating Margin %

For the Specialty Retail subindustry, Innovative Pharmaceutical Biotech's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative Pharmaceutical Biotech's Operating Margin % Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Innovative Pharmaceutical Biotech's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's Operating Margin % falls into.



Innovative Pharmaceutical Biotech Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Innovative Pharmaceutical Biotech's Operating Margin % for the fiscal year that ended in Mar. 2024 is calculated as

Operating Margin %=Operating Income (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=-13.434 / 6.593
=-203.76 %

Innovative Pharmaceutical Biotech's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=-7.222 / 2.866
=-251.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovative Pharmaceutical Biotech  (HKSE:00399) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Innovative Pharmaceutical Biotech Operating Margin % Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Pharmaceutical Biotech Business Description

Traded in Other Exchanges
N/A
Address
145 Hennessy Road, Unit No. 2002, 20th Floor, On Hong Commercial Building, Wan Chai, Hong Kong, HKG
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong.
Executives
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner
Extrawell Pharmaceutical Holdings Limited
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner

Innovative Pharmaceutical Biotech Headlines

No Headlines